Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial-Reference-Cited by-同舟云学术

Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial

Published:2016-03-18 Issue:3 Volume:11 Page:e0151316
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Teymoortash Afshin,Pfestroff Andreas,Wittig Andrea,Franke Nora,Hoch Stephan,Harnisch Susanne,Schade-Brittinger Carmen,Hoeffken Helmut,Engenhart-Cabillic Rita,Brugger Markus,Strauch Konstantin

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas. A retrospective analysis of a monoinstitutional series;H Welz;Oncology,2009

2. Hyperfractionated or accelerated radiotherapy for head and neck cancer;B Baujat;Cochrane Database Syst Rev,2010

3. Radiation-induced xerostomia in patients with head and neck cancer: a literature review;P Dirix;Cancer,2006

5. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review;TL Lovelace;Oral Surg Oral Med Oral Pathol Oral Radiol,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation-associated changes in saliva composition of head and neck cancer patients: A systematic review;Radiotherapy and Oncology;2024-07

2. Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going;Cancer Treatment Reviews;2024-06

3. Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials;Toxins;2024-03-15

4. Botox for the prevention of radiation‐induced Sialadenitis and xerostomia in head and neck cancer patients: A pilot study;Head & Neck;2023-07-04

5. Current management of xerostomia in head and neck cancer patients;American Journal of Otolaryngology;2023-07